Navigation Links
BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
Date:6/16/2009

QUINCY, Mass., June 16 /PRNewswire/ -- BioEnergy International, LLC (BioEnergy), a privately-held, biotech developer and manufacturer of next-generation, renewable biochemicals and biofuels, announces the formation of Myriant Technologies LLC (Myriant) to incorporate all of its biobased chemicals business and intellectual property. BioEnergy will continue its pursuit of biofuels opportunities, including its 110 million gallon per day ethanol plant in Clearfield, Pennsylvania, currently slated for operation in January. The newly-constituted entities will operate as completely separate companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080211/NEM085LOGO )

The move was made pursuant to the company's continuing emergence in the field of biobased chemicals. "It has become clear over time that we've had two distinct companies operating under the same roof, with different technical requirements and serving different markets and customers," said Stephen J. Gatto, Chairman and Chief Executive Officer. "The new alignment will facilitate a clearer understanding and market valuation of each business for both customers and investors alike."

Myriant will encompass the same world-renowned team of molecular biologists, engineers and chemists that successfully developed BioEnergy's D(-) lactic acid, which started production at commercial scale in June 2008 for use in Polylactic Acid (PLA). D(-) lactic acid solves PLA's thermal stability problem, unlocking the vast potential of PLA by expanding its applications to engineering and high performance plastics. "Our unique combination of extraordinary research and development achievement coupled with commercial execution success sets Myriant apart in this field of huge promise," added Mr. Gatto. "With the ongoing rapid commercialization of our biobased Succinic Acid, Myriant will continue to turn the potential for biobased chemicals as an alternative to petroleum into reality."

Headquartered in Quincy, Massachusetts, Myriant also has a fully integrated, state-of-the-art, 18,000 square foot laboratory located in nearby Woburn.

Contact: Samuel G. McConnell, Sr. VP, Corporate Development, (617) 657-5200


'/>"/>
SOURCE BioEnergy International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
2. Universal Bioenergy, Inc. Expressly Disclaims Any Responsibility for the Content, Accuracy of Information, and Quality of Information Regarding Universal Published by Any Third-Party and Being Disseminated on the Internet
3. Atlantica Bioenergy Task Force hosts industry and government leaders
4. Bioenergy D-Ribose Achieves Highest Safety Standard
5. Media Advisory - Atlantica BioEnergy Task Force Leaders Roundtable
6. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
7. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
8. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
9. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
10. Raj Khankari Named Bioenergy, Inc., CEO
11. Atlantica BioEnergy Task Force Unveiled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... ... February 22, 2017 , ... NDA Partners ... MD former Acting Deputy Director in the FDA CDRH Division of Cardiovascular, Respiratory, ... joined the company as an Expert Consultant. , In Dr. Spyker’s accomplished career, ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
Breaking Biology Technology:
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):